Search

Author/Creator Fernando, Shawn

1. Antibody‐drug conjugate MORAb‐202 exhibits long‐lasting antitumor efficacy in TNBC PDx models. Issue 6 (1st May 2021)

Authors:
Furuuchi, Keiji; Rybinski, Katherine; Fulmer, James; Moriyama, Tomoyuki; Drozdowski, Brian; Soto, Allis; Fernando, Shawn; Wilson, Kerrianne; Milinichik, Andrew; Dula, Mary Lou; Tanaka, Keigo; Cheng, Xin; Albone, Earl; Uenaka, Toshimitsu
Journal:
Cancer science
Issue:
Volume 112:Issue 6(2021)
Page Start:
2467
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. CA125 suppresses amatuximab immune-effector function and elevated serum levels are associated with reduced clinical response in first line mesothelioma patients. Issue 7 (3rd July 2018)

Authors:
Nicolaides, Nicholas C.; Schweizer, Charles; Somers, Elizabeth B.; Wang, Wenquan; Fernando, Shawn; Ross, Erin N.; Grasso, Luigi; Hassan, Raffit; Kline, J. Bradford
Journal:
Cancer biology & therapy
Issue:
Volume 19:Issue 7(2018)
Page Start:
622
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗